Site # 391 — Boston, Massachusetts

Site # 391 is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site # 391 has participated in 1 clinical trials.

Therapeutic areas: Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site # 391?

Site # 391 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site # 391 conducted?

Site # 391 has 1 clinical trials on record. Their work covers Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is Site # 391 accredited by Crixeo Clinical Trials?

Site # 391 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site # 391?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.